Radical CyberKnife radiosurgery with tumor tracking: An effective treatment for inoperable small peripheral stage i non-small cell lung cancer

58Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

Objective: Curative surgery is not an option for many patients with clinical stage I non-small-cell lung carcinoma (NSCLC), but radical radiosurgery may be effective. Methods: Inoperable patients with small peripheral clinical stage I NSCLC were enrolled in this study. Three-to-five fiducial markers were implanted in or near tumors under CT guidance. Gross tumor volumes (GTVs) were contoured using lung windows. The GTV margin was expanded by 5 mm to establish the planning treatment volume (PTV). A dose of 42-60 Gy was delivered to the PTV in 3 equal fractions in less than 2 weeks using the CyberKnife radiosurgery system. The 30-Gy isodose contour extended at least 1 cm from the GTV. Physical examination, CT imaging and pulmonary function testing were completed at 6 months intervals for three years following treatment. Results: Twenty patients with an average maximum tumor diameter of 2.2 cm (range, 1.1-3.5 cm) and a mean FEV1 of 1.08 liters (range, 0.53-1.71 L) were treated. Pneumothorax requiring tube thoracostomy occurred following CT-guided fiducial placement in 25% of the patients. All patients completed treatment with few acute side effects and no procedure-related mortality. Transient chest wall discomfort developed in 8 of the 12 patients with lesions within 5 mm of the pleura. The mean percentage of the total lung volume receiving a minimum of 15 Gy was 7.3% (range, 2.4% to 11.3%). One patient who received concurrent gefitinib developed short-lived, grade III radiation pneumonitis. The mean percent predicted DLCO decreased by 9% and 11% at 6 and 12 months, respectively. There were no local failures, regional lymph node recurrences or distant metastases. With a median follow-up of 25 months for the surviving patients, Kaplan-Meier overall survival estimate at 2 years was 87%, with deaths due to COPD progression. Conclusion: Radical CyberKnife radiosurgery is a well-tolerated treatment option for inoperable patients with small, peripheral stage I NSCLC. Effective doses and adequate margins are likely to have contributed to the optimal early local control seen in this study. © 2009 Collins et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Collins, B. T., Vahdat, S., Erickson, K., Collins, S. P., Suy, S., Yu, X., … Anderson, E. D. (2009). Radical CyberKnife radiosurgery with tumor tracking: An effective treatment for inoperable small peripheral stage i non-small cell lung cancer. Journal of Hematology and Oncology, 2. https://doi.org/10.1186/1756-8722-2-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free